Q09YK5 AF NFT

Cystic fibrosis transmembrane conductance regulator

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihpaplqfea4wnhruh24345qsrzypatpku4g4jh53ti5f5z4f6zqb4/metadata.json
IPFS of structure file: 
bafybeic45aqbgnj7cay776d7ooh44fcbtrkimd4ikekx46iaopyqbgiiwi/AF-Q09YK5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x0ED2a1791984b7739f4c67424F27fEEe19fF3Eb0
First NFT owner address (bech32): 
genesis1pmf2z7gesjmh886vvapy7fl7acvl704s0n69pr
Current NFT ID #58959 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
58959
Accession (UniProt):
Q09YK5
Name::
Cystic fibrosis transmembrane conductance regulator
Experimental Method:
Predicted structure
Sequence source:
Ateles geoffroyi

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q09YK5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q09YK5|CFTR_ATEGE Cystic fibrosis transmembrane conductance regulator OS=Ateles geoffroyi OX=9509 GN=CFTR PE=3 SV=1 MQRSPLEKASVVSKLFFSWTRPILKKGYRQRLELSDIYQIPSANSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGILLYLGEVTKAVQPLLLGRIIASYDPDNKTERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKINERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIVLRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNSNNRKTSNGDDNLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAAKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLRPDFSSKLMGYDSFDQFSSERRNSILTETLRRFSLEGDAPVSWTETKKQSFKQTGELGDKRKNSILNSINSIRKFSIVQKTPLQMNGIEENSDEPLERRLSLVPDSEQGEAILPRISVINTGPALQLRRRQSVLNMMTHSVNQGQSVHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDNMESIPAVTTWNTYLRYITLHKSLIFVLIWCLVIFLAEVAASLVVLWFLGNTPFQDKGNSTYSRNNSYAVIITNTSSYYVFYIYVGVADTLLALGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVSVLQPYILLATVPVIAAFILLRAYFLQTSQQLKQLESAGRSPIFTHLVTSLKGLWTIRAFGRQPYFETLFHKALNLHTANWFLYLATLRWFQMRIEIIFVIFFIAVTFISILTTGEGEGTVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKAYKNGQLSKVMIIENSHVKKNDIWPSGGQMTIKDLTAKYIEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFTGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRALKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNEKSLFQQAISHSDRVKLFPHRNSSKYKSPPQIASLKEETEEEVQETRL